Janus Henderson Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,190,686
Closed -$149M 2656
2022
Q3
$149M Sell
2,190,686
-2,287,562
-51% -$156M 0.06% 283
2022
Q2
$143M Sell
4,478,248
-1,125,007
-20% -$35.9M 0.1% 206
2022
Q1
$194M Buy
5,603,255
+120,091
+2% +$4.16M 0.09% 209
2021
Q4
$160M Sell
5,483,164
-789,518
-13% -$23.1M 0.07% 269
2021
Q3
$160M Buy
6,272,682
+104,532
+2% +$2.66M 0.07% 271
2021
Q2
$216M Buy
6,168,150
+285,575
+5% +$10M 0.09% 226
2021
Q1
$240M Sell
5,882,575
-84,287
-1% -$3.43M 0.11% 200
2020
Q4
$258M Buy
5,966,862
+540,580
+10% +$23.4M 0.12% 183
2020
Q3
$299M Buy
5,426,282
+891,029
+20% +$49.1M 0.16% 149
2020
Q2
$286M Sell
4,535,253
-18,728
-0.4% -$1.18M 0.16% 146
2020
Q1
$233M Buy
4,553,981
+1,555,086
+52% +$79.4M 0.16% 145
2019
Q4
$238M Buy
2,998,895
+549,524
+22% +$43.7M 0.12% 191
2019
Q3
$119M Buy
2,449,371
+16,766
+0.7% +$813K 0.06% 318
2019
Q2
$128M Sell
2,432,605
-83,760
-3% -$4.41M 0.07% 313
2019
Q1
$133M Sell
2,516,365
-6,903
-0.3% -$365K 0.07% 309
2018
Q4
$104M Sell
2,523,268
-744,770
-23% -$30.6M 0.07% 335
2018
Q3
$124M Sell
3,268,038
-886,347
-21% -$33.7M 0.07% 338
2018
Q2
$188M Buy
4,154,385
+452,843
+12% +$20.5M 0.11% 242
2018
Q1
$179M Buy
3,701,542
+672,760
+22% +$32.5M 0.11% 237
2017
Q4
$119M Buy
3,028,782
+1,613,224
+114% +$63.5M 0.07% 330
2017
Q3
$44M Buy
1,415,558
+431,325
+44% +$13.4M 0.03% 552
2017
Q2
$26.9M Buy
+984,233
New +$26.9M 0.02% 668